Viewing nowSitagliptin 100 mg (Sitagliptin Hydrochloride Monohydrate)
Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

MFDS item code 202101321 · Approved 2021.02.16 · Insurance code 656005360
Improvement of blood sugar control in type 2 diabetes
This medication is used alongside diet and exercise to help manage blood sugar control in patients with type 2 diabetes. Initially, it is used alone, but if blood sugar control is inadequate, it can be combined with metformin. Additionally, it can be added to other medications for blood sugar control, such as sulfonylureas, metformin, thiazolidinediones, and insulin, when their monotherapy or combination therapy is insufficient. This medication helps provide effective blood sugar management when used with various treatment methods. It improves blood sugar control in type 2 diabetes.
This medication is administered once daily at a dose of 100 mg for monotherapy or combination therapy, with a maximum daily dose of 100 mg. It can be taken irrespective of meals. For patients with renal impairment, dosage adjustment may be required based on kidney function. - Mild renal impairment (eGFR 60 or above to <90): No dosage adjustment necessary - Moderate renal impairment (eGFR 45 or above to <60): No dosage adjustment necessary - Moderate renal impairment (
This medication can rarely cause severe allergic reactions, so if symptoms such as skin rash or difficulty breathing occur, use should be discontinued immediately and medical consultation should be sought. Additionally, serious adverse reactions such as pancreatitis, which is inflammation of the pancreas, have been reported; if symptoms such as abdominal pain, vomiting, or nausea occur, medical personnel should be notified immediately. Patients with type 1 diabetes or those who are hypersensitive to this medication should not use it, and those with impaired kidney function should take caution and adjust the dosage accordingly. When using this medication, hypoglycemic symptoms may occur, so especially when taken with insulin or sulfonylureas, blood sugar levels should be monitored frequently, and attention should be paid to hypoglycemic symptoms. Mild adverse reactions such as headache, upper respiratory tract infection, and nasopharyngitis may occur during treatment, and if severe joint pain or blistering skin symptoms develop, notify a doctor immediately. Women who are pregnant or breastfeeding are advised to avoid using this medication, and the safety in children and adolescents under 18 years old has not been established. Elderly patients may have impaired kidney function, so periodic kidney function tests should be performed before and after taking this medication, and if an overdose occurs, immediate visit to a medical facility for appropriate treatment is required. When used in combination with other drugs, potential interaction should be considered, so consultation with a doctor or pharmacist before use is mandatory.
Hives, severe swelling (angioedema), anaphylaxis, severe allergic reactions, exfoliative skin disorders, Stevens-Johnson syndrome, severe skin adverse reactions, acute pancreatitis, acute renal failure, difficulty breathing, severe edema, severe joint pain with disability, blistering pemphigoid, rhabdomyolysis, liver abnormalities (elevated liver enzymes), cardiac arrest
Not everyone experiences these, and they can vary from person to person.
Store this medication in a sealed container to prevent air from entering. It is best to store at room temperature between 1 to 30 degrees Celsius. This will help maintain the medication's effectiveness for a longer period.
Film-coated tablets that are round, biconvex, and light brown in color
PTP - 28 tablets/box [(14 tablets/PTP×2)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.